Effects of peroxisome proliferator-activated receptor α (PPARα) agonists on leucine-induced phosphorylation of translational targets in C2C12 cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1780, Issue 10, 2008, Pages 1101-1105

  Nakai, Naoya ^a   Kawano, Fuminori ^a   Terada, Masahiro ^a   Oke, Yoshihiko ^a   Ohira, Takashi ^a   Ohira, Yoshinobu ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Leucine; Myoblast; Peroxisome proliferator activated receptor ; Protein translation initiation and elongation; WY 14,643

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CLOFIBRATE; ELONGATION FACTOR 2; INITIATION FACTOR 4B; LEUCINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PIRINIXIC ACID; PROTEIN S6; S6 KINASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME PHOSPHORYLATION; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSLATION INITIATION; WESTERN BLOTTING;

ANIMALS; CARRIER PROTEINS; CELL LINE; CLOFIBRATE; ELONGATION FACTOR 2 KINASE; EUKARYOTIC INITIATION FACTORS; FLAVONOIDS; LEUCINE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MULTIENZYME COMPLEXES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION; PPAR ALPHA; PROTEIN BIOSYNTHESIS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PYRIMIDINES; RIBOSOMAL PROTEIN S6; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIROLIMUS;

EUKARYOTA;

EID: 48949086459     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2008.06.002     Document Type: Article

References (40)

1. Proud C.G. Regulation of mammalian translation factors by nutrients. Eur. J. Biochem. 269 (2002) 5338-5349
2. Anthony J.C., Anthony T.G., Kimball S.R., and Jefferson L.S. Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J. Nutr. 131 (2001) 856S-860S
3. Greiwe J.S., Kwon G., McDaniel M.L., and Semenkovich C.F. Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 281 (2001) E466-471
4. Lynch C.J. Role of leucine in the regulation of mTOR by amino acids: revelations from structure-activity studies. J. Nutr. 131 (2001) 861S-865S
5. Shah O.J., Anthony J.C., Kimball S.R., and Jefferson L.S. 4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E715-729
6. Kimball S.R., Shantz L.M., Horetsky R.L., and Jefferson L.S. Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. J. Biol. Chem. 274 (1999) 11647-11652
7. Long W., Saffer L., Wei L., and Barrett E.J. Amino acids regulate skeletal muscle PHAS-I and p70 S6-kinase phosphorylation independently of insulin. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E301-306
8. Gingras A.C., Raught B., and Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68 (1999) 913-963
9. Brunn G.J., Hudson C.C., Sekulic A., Williams J.M., Hosoi H., Houghton P.J., Lawrence Jr. J.C., and Abraham R.T. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277 (1997) 99-101
10. Redpath N.T., Foulstone E.J., and Proud C.G. Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway. EMBO J. 15 (1996) 2291-2297
11. Wang L., Wang X., and Proud C.G. Activation of mRNA translation in rat cardiac myocytes by insulin involves multiple rapamycin-sensitive steps. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H1056-1068
12. Lefebvre P., Chinetti G., Fruchart J.C., and Staels B. Sorting out the roles of PPARα in energy metabolism and vascular homeostasis. J. Clin. Invest. 116 (2006) 571-580
13. Vamecq J., and Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet 354 (1999) 141-148
14. Leone T.C., Weinheimer C.J., and Kelly D.P. A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7473-7478
15. Aoyama T., Peters J.M., Iritani N., Nakajima T., Furihata K., Hashimoto T., and Gonzalez F.J. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J. Biol. Chem. 273 (1998) 5678-5684
16. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J. Clin. Invest. 103 (1999) 1489-1498
17. Guerre-Millo M., Rouault C., Poulain P., Andre J., Poitout V., Peters J.M., Gonzalez F.J., Fruchart J.C., Reach G., and Staels B. PPAR-α-null mice are protected from high-fat diet-induced insulin resistance. Diabetes 50 (2001) 2809-2814
18. Finck B.N., Bernal-Mizrachi C., Han D.H., Coleman T., Sambandam N., LaRiviere L.L., Holloszy J.O., Semenkovich C.F., and Kelly D.P. A potential link between muscle peroxisome proliferator-activated receptor-α signaling and obesity-related diabetes. Cell Metab. 1 (2005) 133-144
19. Sheikh K., Camejo G., Lanne B., Halvarsson T., Landergren M.R., and Oakes N.D. Beyond lipids, pharmacological PPARα activation has important effects on amino acid metabolism as studied in the rat. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E1157-1165
20. Kobayashi R., Murakami T., Obayashi M., Nakai N., Jaskiewicz J., Fujiwara Y., Shimomura Y., and Harris R.A. Clofibric acid stimulates branched-chain amino acid catabolism by three mechanisms. Arch. Biochem. Biophys. 407 (2002) 231-240
21. Weng Q.P., Kozlowski M., Belham C., Zhang A., Comb M.J., and Avruch J. Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies. J. Biol. Chem. 273 (1998) 16621-16629
22. Holz M.K., Ballif B.A., Gygi S.P., and Blenis J. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123 (2005) 569-580
23. Shahbazian D., Roux P.P., Mieulet V., Cohen M.S., Raught B., Taunton J., Hershey J.W., Blenis J., Pende M., and Sonenberg N. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J. 25 (2006) 2781-2791
24. Mieulet V., Roceri M., Espeillac C., Sotiropoulos A., Ohanna M., Oorschot V., Klumperman J., Sandri M., and Pende M. S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover. Am. J. Physiol. Cell. Physiol. 293 (2007) C712-722
25. RSK1 and p70 S6 kinase. EMBO J. 20 (2001) 4370-4379
26. Hay N., and Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 18 (2004) 1926-1945
27. Inoki K., Zhu T., and Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115 (2003) 577-590
28. Waskiewicz A.J., Flynn A., Proud C.G., and Cooper J.A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16 (1997) 1909-1920
29. Rokos C.L., and Ledwith B.J. Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells. J. Biol. Chem. 272 (1997) 13452-13457
30. Mounho B.J., and Thrall B.D. The extracellular signal-regulated kinase pathway contributes to mitogenic and antiapoptotic effects of peroxisome proliferators in vitro. Toxicol. Appl. Pharmacol. 159 (1999) 125-133
31. Banfi C., Auwerx J., Poma F., Tremoli E., and Mussoni L. Induction of plasminogen activator inhibitor I by the PPARα ligand, Wy-14,643, is dependent on ERK1/2 signaling pathway. Thromb. Haemost. 90 (2003) 611-619
32. Shi Y., Hsu J.H., Hu L., Gera J., and Lichtenstein A. Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6. J. Biol. Chem. 277 (2002) 15712-15720
33. Herbert T.P., Kilhams G.R., Batty I.H., and Proud C.G. Distinct signalling pathways mediate insulin and phorbol ester-stimulated eukaryotic initiation factor 4F assembly and protein synthesis in HEK 293 cells. J. Biol. Chem 275 (2000) 11249-11256
34. Perez de Obanos M.P., Lopez Zabalza M.J., Prieto J., Herraiz M.T., and Iraburu M.J. Leucine stimulates procollagen α1(I) translation on hepatic stellate cells through ERK and PI3K/Akt/mTOR activation. J. Cell. Physiol. 209 (2006) 580-586
35. Guillet C., Prod'homme M., Balage M., Gachon P., Giraudet C., Morin L., Grizard J., and Boirie Y. Impaired anabolic response of muscle protein synthesis is associated with S6K1 dysregulation in elderly humans. FASEB J. 18 (2004) 1586-1587
36. S6K phosphorylation in human skeletal muscle. J. Clin. Endocrinol. Metab. 85 (2000) 4900-4904
37. -/- skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat. Cell Biol. 7 (2005) 286-294
38. Gottlicher M., Widmark E., Li Q., and Gustafsson J.A. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 4653-4657
39. Paul H.S., and Adibi S.A. Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation. J. Clin. Invest. 64 (1979) 405-412
40. Paul H.S., and Adibi S.A. Leucine oxidation and protein turnover in clofibrate-induced muscle protein degradation in rats. J. Clin. Invest. 65 (1980) 1285-1293